IDEX (IEX) AI Stock Analysis

• Market Cap: $12.59B
• Dividend Yield: 1.67%
• Average Volume (3M): 785.49K
• Price to Earnings (P/E): 27.0
• Beta (1Y): 0.99
• Revenue Growth: 4.73%
• EPS Growth: -19.15%
• Country: US
• Employees: 9,000
• Sector: Industrials
• Sector Strength: 83
• Industry: Industrial - Machinery
• EPS (TTM): 2.07
• Shares Outstanding: 75,287,285
• 10 Day Avg. Volume: 937,364
• 30 Day Avg. Volume: 785,492
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 1.16
• Enterprise Value/Revenue: 4.36
• Enterprise Value/Gross Profit: 9.82
• Enterprise Value/Ebitda: 19.32
• 1Y Price Target: $196.56
• Price Target Upside: 17.57% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 10

• Rating: 62 Neutral
• Price Target: $174.00 ▲(4.07% Upside)

The overall stock score for IDEX is primarily influenced by its strong financial performance and strategic growth initiatives. However, bearish technical indicators and revised guidance contribute to a tempered outlook. Valuation concerns also moderate the stock's attractiveness, despite a decent dividend yield.

Positive Factors

Business Resilience

Orders have increased organically for the past five quarters despite existing challenges, demonstrating some resilience in business operations.

Financial Performance

The company reported a 4Q adjusted EPS of $2.04, which beat both the analyst's expectation and the consensus estimate.

Stock Valuation

Shares are trading at the lowest level compared to the S&P since 2009, presenting a potential buying opportunity as margins remain close to all-time highs.

Negative Factors

Investor Sentiment

Investor confidence is low due to the substantial ramp required from weak 1Q.

Market Expectations

The company's 1Q outlook shows a decline in organic sales by 3-4%, which is below consensus expectations of a 3.7% increase.

Order Performance

The orders for the company showed a two-year stack decrease from -1% to -5%, signaling a weaker start to the year.

IDEX Business Overview & Revenue Model

Company Description

IDEX Corporation (IEX) is a diversified industrial company that specializes in the design and manufacture of highly engineered industrial products. Operating primarily in the sectors of fluid and metering technologies, health and science technologies, and fire and safety products, IDEX serves a wide range of markets, including aerospace, agriculture, energy, and water treatment. The company is known for its innovative solutions and strong focus on customer-centric product development.

How the Company Makes Money

IDEX generates revenue through multiple key streams, primarily by selling a diverse portfolio of products and solutions across its various business segments. The company earns money through direct sales of its engineered products, including pumps, valves, and flow measurement devices, which are utilized in critical processes across various industries. Additionally, IDEX benefits from recurring revenue through maintenance and service contracts associated with its products. Significant partnerships with other industrial firms and suppliers enhance its market reach and product offerings, allowing IDEX to capitalize on emerging market trends. Furthermore, IDEX invests in research and development, which helps maintain its competitive edge and drive innovation, further contributing to its revenue growth.

IDEX Financial Statement Overview

Summary

IDEX exhibits a robust financial position with strong profitability margins and low leverage. The company demonstrates efficient cash flow management and solid equity stability, although there is room for improving return on equity and operational efficiency.

Income Statement

IDEX has shown solid performance in the TTM with a slight revenue increase of 0.42% from last year. The gross profit margin is strong at 44.35%, and the net profit margin is healthy at 14.60%. However, the EBIT margin has slightly decreased to 20.16%, and the EBITDA margin stands at 24.27%, indicating stable profitability but a slight decline in operational efficiency.

Balance Sheet

The balance sheet reflects a strong financial position with a low debt-to-equity ratio of 0.03, suggesting low leverage and reduced financial risk. The equity ratio is robust at 57.49%, indicating financial stability. However, the return on equity is moderate at 12.26%, suggesting room for improvement in generating returns for shareholders.

Cash Flow

IDEX's cash flow is stable with an operating cash flow to net income ratio of 1.29, indicating strong cash generation relative to income. However, the free cash flow decreased slightly by 7.49% from the previous year, and the free cash flow to net income ratio is 1.16, showing efficient cash flow management despite the decline.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	3.34B	3.27B	3.27B	3.18B	2.76B	2.35B
Gross Profit	1.48B	1.45B	1.45B	1.43B	1.22B	1.03B
EBITDA	753.80M	859.40M	964.10M	909.80M	720.50M	604.60M
Net Income	469.40M	505.00M	596.10M	586.90M	449.40M	377.80M
Balance Sheet
Total Assets	6.88B	6.75B	5.87B	5.51B	4.92B	4.41B
Cash, Cash Equivalents and Short-Term Investments	568.20M	620.80M	534.30M	430.20M	855.40M	1.03B
Total Debt	800.00K	1.96B	1.45B	1.49B	1.19B	1.04B
Total Liabilities	2.87B	2.95B	2.32B	2.47B	2.11B	1.87B
Stockholders Equity	4.01B	3.79B	3.54B	3.04B	2.80B	2.54B
Cash Flow
Free Cash Flow	601.80M	603.00M	626.80M	489.40M	492.60M	517.73M
Operating Cash Flow	645.30M	668.10M	716.70M	557.40M	565.30M	569.27M
Investing Cash Flow	-1.03B	-1.01B	-283.80M	-917.20M	-698.10M	-172.58M
Financing Cash Flow	450.80M	465.90M	-344.70M	-37.80M	-9.50M	-42.60M

IDEX Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 167.19
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IEX, the sentiment is Negative. The current price of 167.19 is below the 20-day moving average (MA) of 170.66, below the 50-day MA of 175.73, and below the 200-day MA of 192.44, indicating a bearish trend. The MACD of -4.41 indicates Negative momentum. The RSI at 45.94 is Neutral, neither overbought nor oversold. The STOCH value of 83.70 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IEX.

IDEX Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ITT	79 Outperform	$13.06B	26.33	20.17%	0.80%	6.69%	21.44%
GGG	77 Outperform	$14.14B	30.26	19.62%	1.27%	0.75%	-2.74%
PNR	76 Outperform	$17.48B	29.12	17.15%	0.92%	-0.25%	-7.32%
AOS	76 Outperform	$10.00B	19.89	27.60%	1.88%	-3.53%	-7.46%
NDSN	74 Outperform	$12.27B	27.94	15.54%	1.44%	1.98%	-7.66%
Sector *	63 Neutral	$10.80B	16.80	6.58%	2.06%	2.47%	-15.79%
IEX	62 Neutral	$12.59B	26.99	12.25%	1.67%	4.73%	-19.15%

IDEX Corporate Events

IDEX Announces CFO Resignation and Interim Appointment

IDEX Corporation announced the resignation of its Senior Vice President and Chief Financial Officer, Abhishek Khandelwal, effective May 30, 2025. The company has appointed Akhil Mahendra as the interim CFO, who has been with IDEX for two years and previously worked at Rivian Automotive and Morgan Stanley. This transition is not due to any disagreements within the company, and an external search firm has been engaged to find a permanent replacement. The board has approved a restricted stock award for Mahendra, which will vest after three years, contingent on his continued service.

The most recent analyst rating on (IEX) stock is a Hold with a $220.00 price target. To see the full list of analyst forecasts on IDEX stock, see the IEX Stock Forecast page.

IDEX Elects Directors at Annual Stockholder Meeting

On May 8, 2025, IDEX Corporation held its Annual Meeting of Stockholders where key decisions were made. Three Class III directors, Eric D. Ashleman, Stephanie J. Disher, and Matthijs Glastra, were elected for a three-year term. Additionally, the compensation of named executive officers was approved, and Deloitte & Touche LLP was ratified as the independent public accounting firm for 2025. However, a stockholder proposal for a report on hiring practices related to individuals with arrest or incarceration records did not pass.

The most recent analyst rating on (IEX) stock is a Hold with a $220.00 price target. To see the full list of analyst forecasts on IDEX stock, see the IEX Stock Forecast page.